Article info
PDFClinical and epidemiological research
Extended report
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
- Correspondence to Pauline Raaschou, Clinical Epidemiology Unit & Clinical Pharmacology Unit, Department of Medicine, Solna, Karolinska Institutet, T2:01, Stockholm SE-171 76, Sweden; Pauline.raaschou{at}karolinska.se
Citation
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
Publication history
- Received April 14, 2014
- Revised July 8, 2014
- Accepted July 17, 2014
- First published August 8, 2014.
Online issue publication
November 10, 2015
Article Versions
- Previous version (8 August 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/